Marmara University School of Medicine Department of Physical Medicine and Rehabilitation
Istanbul, 34890, Turkey (Türkiye)
NCT Number: NCT04256187
The aim of this study is to quantitatively record the opinions regarding the pros and cons of this treatment of the caregivers of children with cerebral palsy who had botulinum toxin applied in investigators' clinic.
Looking for future studies?
Notify Me18 year–65 year
All sexes
Observational
Istanbul, 34890, Turkey (Türkiye)
Spasticity is defined as an increase in physiological resistance of the muscles associated with a lack of supraspinal inhibition against passive strain. It is a common and prohibitive problem associated with an increase in tendon reflex and tension reflex associated with upper motor neuron dysfunction. One of the most common problems in patients with CP.
Methods used in the treatment of spasticity; medical therapy, physical therapy, intrathecal baclofen pump, botulinum toxin injection, and orthopedic correction operations. However, botulinum toxin type-A (BTX-A) injections, which are applied to the muscles especially for localized spasticity, have become an effective adjuvant option that increases the effectiveness of classical methods and diversifies the treatment options.
BTX-A, which is basically a chemodenervation method; It is a treatment method that blocks the transmission of signal in the neuromuscular junction by preventing the release of acetylcholine vesicles into the presynaptic space. In spastic muscles, relaxation can be achieved by correct injection. Botulinum toxin type A has been shown to be an effective and safe treatment for children to reduce spasticity.
In Turkish society, there is no study evaluating the caregivers' experiences and opinions about botox treatments of patients with the diagnosis of cerebral palsy and limited studies in the literature are from countries with different sociodemographic features such as the United States and the United Kingdom. Although these patients have been receiving this treatment in investigators' center for years, there is no study in the literature that evaluates the plus and minus aspects of caregivers' experiences in this regard.
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Qualitative interviews to sample the patient's feelings, experiences and thoughts risen by the treatments in the program.
Time frame: Day 0
Qualitative interview performed at one occasion where the caregivers describes the experience about the their childrens' botulinum toxin treatment.
Marmara University
Other
Pros and Cons of Botulinum Injection Treatment in Cerebral Palsy: A Qualitative Study Examining the Caregiver's Perspectives
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06117020
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
San Antonio, Texas, United States
View Trial DetailsNCT07613515
Brain Damage, Chronic, Brain Diseases
Jeddah, Saudi Arabia
View Trial DetailsNCT06536751
Brain Damage, Chronic, Brain Diseases
São Paulo, Brazil
View Trial DetailsNCT07346430
Anxiety, Anxiety Disorders
Cairo, Egypt
View Trial Details